Directory
Xavier Matias-Guiu Guia

Xavier Matias-Guiu Guia

Degree: PhD

973 705 340
fjmatiasguiu.lleida.ics(ELIMINAR)@gencat.cat

ResearcherID: http://www.researcherid.com/rid/C-3039-2009

Publications

  • Lerma, E; Matias-Guiu, X; Lee, SJ; Prat, J

    Squamous cell carcinoma of the vulva: Study of ploidy, HPV, p53, and pRb

    INTERNATIONAL JOURNAL OF GYNECOLOGICAL PATHOLOGY 18 191-197. .

    [doi:10.1097/00004347-199907000-00001]

  • Gomez, FJP; Espinosa, MJB; Guia, XMG; Gonzalez, JMR; Palao, JS; Perez, JS; Meseguer, PC; Paricio, PP; Masso, FJT

    Genetic analysis of RET mutations in MEN 2 families from the Community of Murcia, Spain

    MEDICINA CLINICA 112 646-650. .

  • Berna, L; Piera, J; Rodriguez-Espinosa, J; Caixas, A; Puig-Domingo, M; Farrerons, J; Galofre, M; Rousaud, F; Matias-Guiu, X; Estorch, M; Carrio, I

    Double-phase Tc-99m-sestamibi scintigraphy in the localization of abnormal parathyroid glands

    MEDICINA CLINICA 112 201-205. .

  • Gortz, B; Roth, J; Speel, EJM; Krahenmann, A; De Kruger, RR; Matias-Guiu, X; Muletta-Feurer, S; Rutmann, K; Saremaslani, P; Heitz, PU; Komminoth, P

    MEN1 gene mutation analysis of sporadic adrenocortical lesions

    INTERNATIONAL JOURNAL OF CANCER 80 373-379. .

    [doi:10.1002/(SICI)1097-0215(19990129)80:3<373::AID-IJC7>3.0.CO;2-B]

  • Berna, L; Chico, A; Matias-Guiu, X; Mato, E; Catafau, A; Alonso, C; Mora, J; Mauricio, D; Rodriguez-Espinosa, J; Mari, RE; Flotats, A; Martin, JC; Estorch, M; Carrio, I

    Use of somatostatin analogue scintigraphy in the localization of recurrent medullary thyroid carcinoma.

    European Journal Of Nuclear Medicine 25 1482-1488. .

    [doi:10.1007/s002590050325]

  • Carrio, I; Pieri, PL; Narula, J; Prat, L; Riva, P; Pedrini, L; Pretolani, E; Caruso, G; Sarti, G; Estorch, M; Berna, L; Riambau, V; Matias-Guiu, X; Pak, C; Ditlow, C; Chen, F; Khaw, BA

    Noninvasive localization of human atherosclerotic lesions with indium 111-labeled monoclonal Z2D3 antibody specific for proliferating smooth muscle cells

    Journal Of Nuclear Cardiology 5 551-557. .

    [doi:10.1016/S1071-3581(98)90108-8]

  • Chico, A; Gallart, L; Mato, E; Mayoral, C; Martin-Campos, JM; Catasus, L; Rodriguez-Espinosa, J; Matias-Guiu, X; Blanco-Vaca, F; de Leiva, A

    A novel germline mutation in exon 5 of the multiple endocrine neoplasia type 1 gene

    Journal Of Molecular Medicine-Jmm 76 837-839. .

    [doi:10.1007/s001090050288]

  • Catasus, L; Matias-Guiu, X; Machin, P; Munoz, J; Prat, J

    BaX somatic frameshift mutations in endometrioid adenocarcinomas of the endometrium: Evidence for a tumor progression role in endometrial carcinomas with microsatellite instability

    LABORATORY INVESTIGATION 78 1439-1444. .

  • Pujol, RM; Nadal, C; Matias-Guiu, X; Peyri, J; Ferrandiz, C; Palou, J; de Moragas, JM

    Multiple follicular hamartomas with sweat gland and sebaceous differentiation, vermiculate atrophoderma, milia, hypotrichosis, and late development of multiple basal cell carcinomas

    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY 39 853-857. .

    [doi:10.1016/S0190-9622(98)70365-2]

  • Catasus, L; Machin, P; Matias-Guiu, X; Prat, J

    Microsatellite instability in endometrial carcinomas: Clinicopathologic correlations in a series of 42 cases

    HUMAN PATHOLOGY 29 1160-1164. .

    [doi:10.1016/S0046-8177(98)90430-0]

  • Matias-Guiu, X; Prat, J

    Molecular pathology of ovarian carcinomas

    VIRCHOWS ARCHIV 433 103-111. .

    [doi:10.1007/s004280050224]

  • Matias-Guiu, X; Pons, C; Prat, J

    Mullerian inhibiting substance, alpha-inhibin, and CD99 expression in sex cord-stromal tumors and endometrioid ovarian carcinomas resembling sex cord-stromal tumors

    HUMAN PATHOLOGY 29 840-845. .

    [doi:10.1016/S0046-8177(98)90454-3]

Projects

  • Homologous recombination deficiency in high-grade endometrial cancers. Biomarkers and impact of intratumor heterogeneity.
  • EPH Receptor Signaling in Endometrial Cancer
  • Ajuts per a la contractació de personal investigador novell (FI)
  • Personalized Immunotherapy for Endometrial Cancer; Acronym: ExCITE (Endometrial Cancer Immunotherapy)
  • "Multi-Omics data for Cancer Research and the Development of New Diagnostics and Therapies"
  • EFFICACY: Nuevas estrategias para incrementar efectividad de los tratamientos con ABTL0812
  • Incorporación de nuevas areas temáticas y nuevos grupos al consorcio CIBER
  • Perfiles epigenéticos asociados a patrones de metastasis en cáncer de endometrio
  • CONTRACTES D'INCORPORACIO DE CIENTIFICS I TECNOLEGS: INCORPORACIO D'UNA DOCTORA PER A L'ACCIO ANTITUMORAL DELS CANNABINOIDES EN EL CARCINOMA D'ENDOMETRI
  • DISCOVERY, VALIDATION AND IMPLEMENTATION OF BIOMARKERS FOR PRECISION ONCOLOGY
  • Desarrollo de nuevas aproximaciones en el manejo individualizado de pacientes con cancer ginecológico (PREDICTGYN)
  • VALIDACION DE ANEXINA 2 COMO PREDICTOR DE RECIDIVA EN EL CANCER DE ENDOMETRIO. DISEÑO DE NUEVAS ESTRATEGIAS TERAPEUTICAS. ANXARECU